Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.005 CAD 0.00(0%)
Last update at 2026-11-10T14:30:00Z
Market Cap
0.16M

Momentum Score

…

MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada, the United States, and Malaysia. The company offers MyndLink, an AI-powered system designed to enhance spinal cord stimulation (SCS) treatment outcomes by providing real-time, data-driven recommendations; MyndMove, a non-invasive functional electrical stimulation therapy designed to improve voluntary arm and hand function in patients with upper-limb paralysis, such as those suffering from stroke or spinal cord injury; and cell regeneration technology for the treatment of neurological diseases. It also provides MyndSearch or MyndStep devices to clinics and research institutions, as well as treatment supplies. The company was formerly known as Simple Systems Inc. and changed its name to MyndTec Inc. in April 2013. MyndTec Inc. was incorporated in 2008 and is headquartered in Mississauga, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for MyndTec Inc. (MYTC.CN) are limited, so the company's core business and financial position are not clearly described in widely available sources. Any long-term growth would likely depend on successful product development, market entry, regulatory approvals or strategic partnerships, which could support revenue if execution succeeds.

Key risks include low liquidity, limited operating history or revenues, execution and financing risk, competitive pressure and regulatory uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-
ROE
-
Net Debt
0.35M
ROCE
102.15%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.25M -1.72M -2.13M -3.05M -1.49M
Net income -1.25M -1.72M -2.13M -3.05M -1.49M
Selling general administrative 0.80M 1.00M 1.31M 1.34M 1.50M
Gross profit 0.00M 0.05M 0.07M 0.35M 0.07M
Reconciled depreciation 0.10M 0.12M 0.13M 0.11M 0.12M
Operating income -1.23M -1.59M -2.03M -2.72M -1.71M
Interest expense 0.02M 0.02M 0.12M 0.32M 0.23M
Interest income 0.00M - 0.01M 0.00M -
Net interest income -0.02M -0.02M -0.11M -0.32M -0.23M
Total revenue 0.11M 0.14M 0.26M 0.61M 0.16M
Total operating expenses 1.34M 1.73M 2.29M 3.32M 1.87M
Cost of revenue 0.11M 0.08M 0.19M 0.25M 0.10M
Total other income expense net 0.00M -0.11M 0.01M -0.01M 0.44M
Net income from continuing ops -1.25M -1.72M -2.13M -3.05M -1.49M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.31M 0.55M 0.64M 3.82M 1.65M
Total liab 1.55M 1.47M 1.57M 7.37M 3.48M
Total stockholder equity -1.24M -0.92M -0.93M -3.54M -1.83M
Other current liab -0.00M - 0.49M 2.71M 0.19M
Capital stock 15.72M 14.97M 13.85M 11.01M 10.09M
Retained earnings -20.93M -19.68M -17.96M -15.82M -12.77M
Cash 0.12M 0.19M 0.07M 0.38M 0.67M
Total current liabilities 1.51M 1.44M 1.27M 5.75M 1.05M
Net debt 0.35M 0.26M 0.17M 1.65M 1.04M
Short long term debt 0.44M 0.45M 0.46M 1.43M -
Total current assets 0.27M 0.44M 0.40M 3.48M 1.34M
Net receivables 0.00M 0.01M 0.03M 0.28M 0.17M
Long term debt 0.02M - 0.24M 0.59M 1.71M
Inventory 0.12M 0.18M 0.26M 0.30M 0.32M
Accounts payable 0.33M 0.24M 0.20M 1.55M 0.64M
Non current assets total 0.04M 0.12M 0.24M 0.34M 0.31M
Capital lease obligations 0.00M 0.01M 0.01M 0.05M 0.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.02M 0.00M -0.04M -0.06M -0.02M
Net borrowings -0.01M -0.03M -0.15M -0.21M -
Total cash from financing activities 0.87M 1.10M 2.08M 1.21M 1.67M
Net income -1.25M -1.72M -2.13M -3.05M -1.49M
Change in cash -0.07M 0.12M -0.31M -0.29M 0.25M
Begin period cash flow 0.19M 0.07M 0.38M 0.67M 0.42M
End period cash flow 0.12M 0.19M 0.07M 0.38M 0.67M
Total cash from operating activities -0.92M -0.98M -2.34M -1.44M -1.40M
Issuance of capital stock 0.88M 1.15M 2.26M 0.83M 0.10M
Depreciation 0.10M 0.12M 0.11M 0.11M 0.12M
Change to inventory 0.07M 0.07M 0.05M 0.02M -0.02M
Change to account receivables - - - -0.14M 0.16M
Capital expenditures 0.02M 0.00M 0.04M 0.06M 0.02M
Change in working capital 0.18M 0.32M -0.69M 0.96M 0.11M
Stock based compensation 0.05M 0.20M 0.24M 0.13M 0.10M
Other non cash items 0.00M 0.11M 0.10M 0.42M -0.22M
Free cash flow -0.94M -0.98M -2.39M -1.50M -1.41M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MYTC
MyndTec Inc.
-
-%
0.01 - - 0.99 61.93 3.76 -8.57
BLO
Cannabix Technologies Inc
-0.04
9.09%
0.35 - - 556.83 57.80 564.68 -11.28
ASTI
Aquarius Surgical Technologies Inc
-
-%
0.01 - - 5.52 31.44 96.08 56.94

Profile*

MyndTec Inc.

MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada, the United States, and Malaysia. The company offers MyndLink, an AI-powered system designed to enhance spinal cord stimulation (SCS) treatment outcomes by providing real-time, data-driven recommendations; MyndMove, a non-invasive functional electrical stimulation therapy designed to improve voluntary arm and hand function in patients with upper-limb paralysis, such as those suffering from stroke or spinal cord injury; and cell regeneration technology for the treatment of neurological diseases. It also provides MyndSearch or MyndStep devices to clinics and research institutions, as well as treatment supplies. The company was formerly known as Simple Systems Inc. and changed its name to MyndTec Inc. in April 2013. MyndTec Inc. was incorporated in 2008 and is headquartered in Mississauga, Canada.

1900 Minnesota Court, Mississauga, ON, Canada, L5N 3C9

888-363-0581

Name Title Year Born
Mr. Craig Leon MBA CEO & Director 1968
Mr. Jing Peng Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…